spacer
spacer

PDBsum entry 3cs8

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
Nuclear protein PDB id
3cs8
Contents
Protein chains
269 a.a.
12 a.a.
Ligands
SO4 ×4
BRL
Waters ×88

References listed in PDB file
Key reference
Title Structural and biochemical basis for the binding selectivity of peroxisome proliferator-Activated receptor gamma to pgc-1alpha.
Authors Y.Li, A.Kovach, K.Suino-Powell, D.Martynowski, H.E.Xu.
Ref. J Biol Chem, 2008, 283, 19132-19139. [DOI no: 10.1074/jbc.M802040200]
PubMed id 18469005
Abstract
The functional interaction between the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivator PGC-1alpha is crucial for the normal physiology of PPARgamma and its pharmacological response to antidiabetic treatment with rosiglitazone. Here we report the crystal structure of the PPARgamma ligand-binding domain bound to rosiglitazone and to a large PGC-1alpha fragment that contains two LXXLL-related motifs. The structure reveals critical contacts mediated through the first LXXLL motif of PGC-1alpha and the PPARgamma coactivator binding site. Through a combination of biochemical and structural studies, we demonstrate that the first LXXLL motif is the most potent among all nuclear receptor coactivator motifs tested, and only this motif of the two LXXLL-related motifs in PGC-1alpha is capable of binding to PPARgamma. Our studies reveal that the strong interaction of PGC-1alpha and PPARgamma is mediated through both hydrophobic and specific polar interactions. Mutations within the context of the full-length PGC-1alpha indicate that the first PGC-1alpha motif is necessary and sufficient for PGC-1alpha to coactivate PPARgamma in the presence or absence of rosiglitazone. These results provide a molecular basis for specific recruitment and functional interplay between PPARgamma and PGC-1alpha in glucose homeostasis and adipocyte differentiation.
Figure 3.
FIGURE 3. Purification and crystallization of the PPAR LBD complexed with a PGC-1 fragment. A, a schematic representation showing the PGC-1 protein and its two receptor-interacting motifs (ID1 and ID2). The PGC-1 fragment (101-220) that includes both ID1 and ID2 motifs was used in cocrystallization with PPAR . B, purification of the PPAR LBD and PGC-1 complex. The proteins of PPAR and PGC-1 were purified separately and complexed using excess PGC-1 in the presence of rosiglitazone. The PPAR ·PGC-1 complex and PGC-1 alone were separated by gel filtration. The complex was eluted in the first peak and collected and concentrated to 10 mg/ml for the crystallization trial. C, the protein complex samples shown on an SDS gel. The molecular mass markers are shown in the KD lane (kilodaltons). Lanes 1-9 are fractions from the gel filtration column corresponding to the two peaks in B, from left to right. D, crystals of the PPAR ·rosiglitazone·PGC-1 complex.
Figure 6.
FIGURE 6. Molecular determinants of the PGC-1 /PPAR interactions. A and B, the docking mode of PGC-1 ID1 (yellow) on the surface of PPAR (coactivator binding site) is shown. The hydrophobic interaction is shown in A, and the specific intermolecular interaction is shown in B. C and D, the binding interface of PGC-1 /PPAR shows the specific intermolecular and intramolecular interactions. The PGC-1 is shown in green, the PPAR is in red, and the hydrogen bonds are shown as arrows.
The above figures are reprinted by permission from the ASBMB: J Biol Chem (2008, 283, 19132-19139) copyright 2008.
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer